B

Bioretec Oy
OMXH:BRETEC

Watchlist Manager
Bioretec Oy
OMXH:BRETEC
Watchlist
Price: 1.995 EUR -0.75% Market Closed
Market Cap: 40.6m EUR
Have any thoughts about
Bioretec Oy?
Write Note

Bioretec Oy
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Bioretec Oy
Cash & Cash Equivalents Peer Comparison

Comparables:
R
REG1V
M
MODU
O
OPTOMED
N
NXTMH
B
BIOBV

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
B
Bioretec Oy
OMXH:BRETEC
Cash & Cash Equivalents
€6.9m
CAGR 3-Years
45%
CAGR 5-Years
41%
CAGR 10-Years
N/A
R
Revenio Group Oyj
OMXH:REG1V
Cash & Cash Equivalents
€21.5m
CAGR 3-Years
-9%
CAGR 5-Years
16%
CAGR 10-Years
17%
M
Modulight Oyj
OMXH:MODU
Cash & Cash Equivalents
€409k
CAGR 3-Years
-39%
CAGR 5-Years
-21%
CAGR 10-Years
N/A
O
Optomed Oyj
OMXH:OPTOMED
Cash & Cash Equivalents
€7.1m
CAGR 3-Years
-12%
CAGR 5-Years
29%
CAGR 10-Years
N/A
N
Nexstim Oyj
OMXH:NXTMH
Cash & Cash Equivalents
€3m
CAGR 3-Years
-23%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
B
Biohit Oyj
OMXH:BIOBV
Cash & Cash Equivalents
€1.8m
CAGR 3-Years
22%
CAGR 5-Years
7%
CAGR 10-Years
20%

See Also

What is Bioretec Oy's Cash & Cash Equivalents?
Cash & Cash Equivalents
6.9m EUR

Based on the financial report for Dec 31, 2023, Bioretec Oy's Cash & Cash Equivalents amounts to 6.9m EUR.

What is Bioretec Oy's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
41%

Over the last year, the Cash & Cash Equivalents growth was 465%. The average annual Cash & Cash Equivalents growth rates for Bioretec Oy have been 45% over the past three years , 41% over the past five years .

Back to Top